Literature DB >> 24834177

Dubin-Johnson syndrome presenting after acute viral hepatitis.

Farhad Lahmi1, Mohammad Roshani1, Katayoun Khosravi1, Morteza Azizi1, Seyed Reza Mohebbi1, Mohammad Reza Zali1.   

Abstract

Elevated serum level of bilirubin is a common manifestation which is occurred in several diseases. Hyperbilirubinemia can manifest either conjugated or unconjugated. Conjugated or direct hyperbilirubinemia usually are caused by hepatocellular diseases or cholestatic liver diseases. Merely conjugated hyperbilirubinemia is the main manifestation of two congenital syndromes, including Dubin-Johnson and rotor syndrome; however it can be seen in some patients with recurrent benign intrahepatic cholestasis. This article reports a patient with Dubin- Johuson syndrome as a benign and rare condition.

Entities:  

Keywords:  Conjugated hyperbilirubinemia; Dubin-Johnson syndrome; Viral hepatitis

Year:  2011        PMID: 24834177      PMCID: PMC4017419     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol Bed Bench        ISSN: 2008-2258


Introduction

The Dubin-Johnson syndrome (DJS) is characterized by a conjugated hyperbilirubinemia. The inheritance is autosomal recessive. The highest prevalence is seen in Sephardic Jews from Iran and Iraq that is 1:3000 who also often have an associated coagulation factor VII deficiency (1–4). Dubin Johnson syndrome manifests with an intermittent jaundice in the first two decades of life. Pregnancy or intake of oral contraceptive may provoke manifestation of the disease. Except for the jaundice most patients have no other complaints. The prognosis and development of DJS is benign (5).

Case Report

The patient is a 22-year old male that came to the office 3 year ago for the first time with fever, jaundice, fatigue and dark urine. He had no complaint of pruritus, abdominal pain and GI-bleeding. He had no history of alcohol intake or any drug use (herbal or chemical). Family history for liver disease is negative. In that period of time liver function test were impaired and all serological studies was normal but HAVab IgM was positive, the patient was being treated with the suspicion of acute viral hepatitis A (Table 1).
Table 1

Paraclinical Evaluations from first presentation until present

During first attackIn past 3 years after first attackCurrent
AST(IU/L)1253319
ALT(IU/L)2713123
ALP(IU/L)221240184
INR1.41.21.1
Alb(gr/dl)3.33.83.6
α-1 AntiTrypsinNormalNormalNormal
Anti LKM AbNegativeNegativeNegative
ANA,ASMANegativeNegativeNegative
HBS Ag, HBC Ab (IgM/IgG)NegativeNegativeNegative
HCVAB, HIVABNegativeNegativeNegative
HAVAB (total)PositivePositivePositive
HAV Ab(IgM)PositivePositiveNegative
HAV Ab(IgG)NegativeNegativePositive
CeruloplasminNormalNormalNormal
TSHNormalNormalNormal
S.P. electrophoresisNormalNormalNormal
Anti EMA(IgG,IgM)NegativeNegativeNegative
P-ANCANegativeNegativeNegative
Total Bilirubin (mg/dl)11.913.58.9
Direct Bilirubin (mg/dl)9.39.57.4

AST= aspartate aminotransferase; ALT= Alanine transaminase; ALP= Alkaline phosphatase; INR= International normalized ratio; Alb= Albumin; LKM Ab= liver kidney microsome antibody; ASMA= Anti-Smooth Muscle Antibody; ANA= Antinuclear Antibody; Ab= Antibody; Ag= Antigen; Ig= Immunoglobulin; HBS= hepatitis B surface; HBC= Hepatitis B Core; HCV= Hepatitis Virus Type C; HIV= Human immunodeficiency virus; HAV= Hepatitis A virus; TSH= thyroid stimulating hormone; S.P= Serum Protein; EMA= Endomysial Antibody; P-ANCA= Perinuclear Anti-Neutrophil Cytoplasmic Antibody

Paraclinical Evaluations from first presentation until present AST= aspartate aminotransferase; ALT= Alanine transaminase; ALP= Alkaline phosphatase; INR= International normalized ratio; Alb= Albumin; LKM Ab= liver kidney microsome antibody; ASMA= Anti-Smooth Muscle Antibody; ANA= Antinuclear Antibody; Ab= Antibody; Ag= Antigen; Ig= Immunoglobulin; HBS= hepatitis B surface; HBC= Hepatitis B Core; HCV= Hepatitis Virus Type C; HIV= Human immunodeficiency virus; HAV= Hepatitis A virus; TSH= thyroid stimulating hormone; S.P= Serum Protein; EMA= Endomysial Antibody; P-ANCA= Perinuclear Anti-Neutrophil Cytoplasmic Antibody In the recent past 3 years total bilirubin has been fluctuates between 8.9- 13.5 mg/dL and the direct part between 7.4-9.5 mg/dL. Despite the regression of symptoms and reduction of liver enzymes to the normal levels, the jaundice remained persistent (Table 1). Abdominal sonography in 3 years ago revealed nothing significant but mild hepatomegaly with heterogenous echo. Recently, liver biopsy was done and containing a specimen consisting of two pieces of small creamy needle-shaped dark brown tissue totally measuring 3 cm in length and 0.1 cm in diameter. Sections show intact lobular and vascular architecture. Individual hepatocytes contain abundant course brown pigment granules especially in perivenular areas portal tracts show mild lymphocytic infiltration. Masson trichrome shows no significant fibrosis and other special stains were negative. These features were compatible with clinical diagnosis of DJS (Figure 1).
Figure 1

Histopathological view of liver needle biopsy shows intact lobular and vascular architecture. Individual hepatocytes contain abundant coarse brown pigment granules especially in perivenular areas. Portal tracts show mild lymphocytic infiltration.

Histopathological view of liver needle biopsy shows intact lobular and vascular architecture. Individual hepatocytes contain abundant coarse brown pigment granules especially in perivenular areas. Portal tracts show mild lymphocytic infiltration. He had one episode of upper GI bleeding that Esophagogastroduodenoscopy revealed grade B esophagitis and small duodenal ulcer. In urine Coproporphyrin study 88% of urinary Coproporphyrin was type I.

Discussion

DJS is listed as a rare disease by the office of rare disease (ORD) of the national institutes of Health (NIH) (6, 7). In this situation we see no clinical and laboratory findings except prolonged jaundice. The diagnosis is based on clinical and laboratory findings especially liver biopsy. Despite the normal liver enzymes, only the bilirubin is higher than normal level that is mainly conjugated part. In liver biopsy we can see pigmented brownish granules (8, 9). Diagnosis can be confirmed by the measurement of urine Coproporphyrin. The total Coproporphyrin in urine is normal, but 85-90% of urinary Coproporphyrin is type I, whereas in normal persons 75% of urinary Coproporphyrin is type III (7, 9, 10). In our patient the jaundice was being provoked after a viral hepatitis and despite comprehensive work up, only direct hyperbilirubinemia was seen. The prognosis of DJS is favorable with a normal life expectancy. A therapy is neither available nor required (11).
  10 in total

1.  Dubin-Johnson syndrome: report of a case occurring in a Negro male.

Authors:  D BERKOWITZ; J ENTINE; L CHUNN
Journal:  N Engl J Med       Date:  1960-05-19       Impact factor: 91.245

2.  Familial DubinJohnson syndrome.

Authors:  S BEKER; A E READ
Journal:  Gastroenterology       Date:  1958-10       Impact factor: 22.682

3.  Chronic idiopathic jaundice; a review of fifty cases.

Authors:  I N DUBIN
Journal:  Am J Med       Date:  1958-02       Impact factor: 4.965

4.  A new diagnostic approach to the Dubin-Johnson syndrome.

Authors:  T Pinós; J M Constansa; A Palacin; C Figueras
Journal:  Am J Gastroenterol       Date:  1990-01       Impact factor: 10.864

5.  Cholecystitis in a 17-year-old boy with recurrent jaundice since childhood.

Authors:  C Sotelo-Avila; R K Danis; J Krafcik; M Malik; K B Schwarz
Journal:  J Pediatr       Date:  1988-04       Impact factor: 4.406

6.  Diagnostic and pathogenetic implications of urinary coproporphyrin excretion in the Dubin-Johnson syndrome.

Authors:  M Frank; M Doss; D G de Carvalho
Journal:  Hepatogastroenterology       Date:  1990-02

7.  Coproporphyrin excretion in amniotic fluid and urine from premature infants: a possible maturation defect.

Authors:  A W Wolkoff; I M Arias
Journal:  Pediatr Res       Date:  1974-05       Impact factor: 3.756

8.  Dubin-Johnson syndrome in immature sheep.

Authors:  C E Cornelius; B I Osburn; R R Gronwall; G H Cardinet
Journal:  Am J Dig Dis       Date:  1968-12

Review 9.  The canalicular multispecific organic anion transporter and conjugated hyperbilirubinemia in rat and man.

Authors:  C C Paulusma; R P Oude Elferink
Journal:  J Mol Med (Berl)       Date:  1997-06       Impact factor: 4.599

Review 10.  Dubin-Johnson and Rotor syndromes: molecular basis and pathogenesis.

Authors:  P Zimniak
Journal:  Semin Liver Dis       Date:  1993-08       Impact factor: 6.115

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.